Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome | Pharmacology
Figure 1 | Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Targeting CD20: Monoclonals of the future - ppt download
Chemical & Engineering News: Top Pharmaceuticals: Rituxan
Rituximab mode of action. Rituximab is a monoclonal antibody that... | Download Scientific Diagram
Empowering Targeted Therapy: Lessons from Rituximab
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Rituximab: Mechanism of Action - ScienceDirect
Obinutuzumab for the treatment of non-Hodgkin lymphomas
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab - ScienceDirect
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Rituximab (Rituxan) | American Journal of Neuroradiology
Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma - Annals of Oncology
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab - Wikipedia
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rituximab | Immunopaedia
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Rituximab mechanisms of action; the three major independent mechanisms... | Download Scientific Diagram
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
